RonaldSteisMD

PubMed

• 28 citations
  A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated...
  Joyce O'Shaughnessy, Angela DeMichele, Cynthia X. Ma, Paul Richards, Denise A. Yardley, Gail S. Wright, Kevin Kalinsky, Ronald Steis, Sami Diab, Gerard Kennealey, Ryan...> ;Breast Cancer Research and Treatment. 2018 Apr 19
• 2 citations
  Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.
  Aleksandra Vidisheva, James Wang, Tanya M. Spektor, Jacob D. Bitran, Jose Lutzky, Imad A. Tabbara, Joseph Z. Ye, Sikander Ailawadhi, Laura Stampleman, Ronald G. Steis,...> ;Supportive Care in Cancer. 2017 Apr 28
• 49 citations
  Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
  Chandra P. Belani, Marshall T. Schreeder, Ronald G. Steis, Richard A. Guidice, Thomas A. Marsland, Elizabeth H. Butler, Suresh S. Ramalingam> ;Cancer. 2008 Nov 1
• 65 citations
  Induction of Immune Responses and Clinical Efficacy in a Phase II Trial of IDM-2101, a 10-Epitope Cytotoxic T-Lymphocyte Vaccine, in Metastatic Non–Small-Cell Lung Cancer
  Minal A. Barve, J G Bender, N. Senzer, C. Cunningham, F. Anthony Greco, David McCune, Ronald Steis, Hung Khong, Donald A. Richards, Joe Stephenson, Prasanthi Ganesa, J...> ;Journal of Clinical Oncology. 2008 Sep 20
• Induction of immune responses and clinical activity in a phase II trial of IDM-2101, a 10-epitope CTL vaccine, in metastatic NSCLC patients.
  Barve M, Bender J, Pappen B, Ishioka G, Morse MA, Greco FA, McCune D, Steis R, Khong H, Nemunaitis JJ> ;J. Clin. Oncol.. 2008-05-20
• A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer (An International Oncology Network study, #I-04-015).
  Waples JM, Auerbach M, Steis R, Boccia RV, Wiggans RG> ;J. Clin. Oncol.. 2008-05-20
• A phase II trial of single-agent vinflunine as second-line treatment for advanced non-small cell lung cancer (An International Oncology Network Study, #I-05-009).
  Joppert M, Knapp M, Dakhil SR, Boccia RV, Steis R, Jones CM> ;J. Clin. Oncol.. 2008-05-20
• 60 citations
  Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multi...
  James R. Berenson, Ralph V. Boccia, David A. Siegel, Marek Bozdech, Alberto Bessudo, Edward A. Stadtmauer, J. Talisman Pomeroy, Ronald G. Steis, Marshall S. Flam, Jose...> ;British Journal of Haematology. 2006 Oct 1
• Initial therapeutic strategy in follicular lymphoma (FL): An analysis from the National LymphoCare Study (NLCS).
  Friedberg JW, Huang J, Dillon H, Farber C, Feliciano S, Hainsworth J, Link B, Steis R, Vose J, Zelenetz A> ;J. Clin. Oncol.. 2006-06-20
• Risk factors for gastrointestinal perforations in patients with metastatic colorectal cancer receiving bevacizumab plus chemotherapy.
  Sugrue M, Kozloff M, Hainsworth J, Badarinath S, Cohn A, Flynn P, Steis R, Dong W, Sarkar S, Grothey A> ;J. Clin. Oncol.. 2006-06-20
• Efficacy of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in...
  Kozloff M, Hainsworth J, Badarinath S, Cohn A, Flynn P, Steis R, Dong W, Suzuki S, Sugrue M, Grothey A> ;J. Clin. Oncol.. 2006-06-20
• A phase I/II study of Xcellerated T Cells in patients with chronic lymphocytic leukemia.
  Kipps TJ, Wierda WG, Castro JE, Keating MJ, Boccia RV, Steis R, Meyer J, Berenson RJ, Frohlich MW> ;J. Clin. Oncol.. 2005-06-01
• 9 citations
  Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Netw...
  A. A. Meluch, F. Anthony Greco, H B A Lisa Morrissey, Eric L. Raefsky, Ronald G. Steis, James A. Butts, John D. Hainsworth> ;Cancer. 2003 Nov 15
• 153 citations
  Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network
  A. A. Meluch, F. Anthony Greco, Howard A. Burris, Timothy J. O'Rourke, Gregory L. Ortega, Ronald G. Steis, Lisa H. Morrissey, Valerie Johnson, John D. Hainsworth> ;Journal of Clinical Oncology. 2001 Jun 15
• 6 citations
  A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma.
  Barry L. Gause, W. H. Sharfman, John E. Janik, Brendan D. Curti, Ronald G. Steis, Urba Wj, Smith Jw nd, Alvord Wg, Dan L. Longo> ;Cancer Investigation. 1998 Jan 1
• 13 citations
  A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma.
  , , , , , , , , , , , , , , , , , , , > ;Journal of Immunotherapy With Emphasis on Tumor Immunology. 1996 Sep 1
• 15 citations
  Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer.
  Barry L. Gause, M Sznol, William C. Kopp, John E. Janik, Ronald G. Steis, W J Urba, William Sharfman, Robert G. Fenton, S P Creekmore, Jon Holmlund, Kevin C. Conlon, L...> ;Journal of Clinical Oncology. 1996 Aug 1
• 18 citations
  Phase II Trial of Interleukin 1α and Indomethacin in Treatment of Metastatic Melanoma
  , , , , , , , , , , , , , , , , , > ;Journal of the National Cancer Institute. 1996 Jan 3
• 3 citations
  Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma.
  W. H. Sharfman, W J Urba, John E. Janik, Brendan D. Curti, Barry L. Gause, Jon Holmlund, Ronald G. Steis, A. E. Beauchamp, Dan L. Longo> ;International Journal of Oncology. 1995 Mar 1
• 4 citations
  A Phase I Clinical Trial of Flavone-8-Acetic Acid in Combination With Interleukin 2
  , , , , , , , , , , , , , , , , > ;Journal of the National Cancer Institute. 1995 Jan 18
• 25 citations
  T-cell receptor gene rearrangement in T-cell large granular leukocyte leukemia: preferential V alpha but diverse J alpha usage in one of five patients
  Claude Kasten-Sportes, Sara Zaknoen, Ronald G. Steis, Wing C. Chan, Elliott F. Winton, Thomas A. Waldmann> ;Blood. 1994 Feb 1
• 135 citations
  Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.
  Marc E. Horowitz, Timothy J. Kinsella, Leonard H. Wexler, Jean B. Belasco, Timothy J. Triche, Maria Tsokos, Seth M. Steinberg, L McClure, Dan L. Longo, Ronald G. Steis> ;Journal of Clinical Oncology. 1993 Oct 1
• 17 citations
  Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanoma.
  William C. Kopp, J W Smith nd, C H Ewel, W G Alvord, C Main, P M Guyre, Ronald G. Steis, Dan L. Longo, W J Urba> ;Journal of Immunotherapy With Emphasis on Tumor Immunology. 1993 Apr 1
• 28 citations
  Dose-related immunologic effects of levamisole in patients with cancer
  John E. Janik, William C. Kopp, J W Smith nd, Dan L. Longo, W G Alvord, W. H. Sharfman, Robert G. Fenton, M Sznol, Ronald G. Steis, S P Creekmore> ;Journal of Clinical Oncology. 1993 Jan 1
• 131 citations
  The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.
  J W Smith nd, W J Urba, Brendan D. Curti, L J Elwood, Ronald G. Steis, John E. Janik, W. H. Sharfman, Langdon L. Miller, Robert G. Fenton, Kevin C. Conlon> ;Journal of Clinical Oncology. 1992 Jul 1
• Join now to see all